CTRI/2019/01/017089
Recruiting
未知
A prospective, observational, Multicenter study to evAluate safety and effIcacy of cilniDipine, mEtoprolol succinate and chlorthalidoNe in high risk hypertensive patients
Aprica Healthcare Pvt Ltd0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: I10- Essential (primary) hypertension
- Sponsor
- Aprica Healthcare Pvt Ltd
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Patients willing to provide written informed consent form
- •2\.Male or Female patients aged 18 years and above
- •3\.Essential hypertension which is uncontrolled (defined as systolic BP \>\= 140 mmHg or diastolic BP \>\= 90 mmHg ) on dual anti\-hypertensive agents
- •4\.Patients treated with cilnidipine, metoprolol succinate and chlorthalidone
Exclusion Criteria
- •1\. Patients receiving any other antihypertensive other than cilnidipine, metoprolol succinate and chlorthalidone
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 4
Observation on the efficacy of Tripterygium wilfordii polyglycosides tablets combined with Adamumab in the treatment of rheumatoid arthritisrheumatoid arthritisITMCTR2100005277The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine
Completed
Not Applicable
A Prospective, multicenter, observational study to identify deleterious novel variants of the DPYD gene in patients of non-Western descent: The DPYD-NOW studyCancer (breastcancercolorectal cancergastric cancer)10027656NL-OMON49023eids Universitair Medisch Centrum22
Not yet recruiting
Phase 4
An Observational study to evaluate the safety and effectiveness of Rejoint Max® in Indian Patients with Osteoarthritis of KneeHealth Condition 1: M170- Bilateral primary osteoarthritis of kneeCTRI/2020/03/023852Abbott Healthcare Pvt Ltd
Recruiting
Not Applicable
Observational study to evaluate safety and efficacy of fix dose combination of Metformin, glimePiride, and voglibose in Type 2 diabetes mellitus patientsHealth Condition 1: E118- Type 2 diabetes mellitus with unspecified complicationsCTRI/2019/01/017128Aprica Healthcare Pvt Ltd
Recruiting
Not Applicable
Evaluation of the Therapeutic Effects of a Combination Drug Containing Amlodipine, Losartan, Rosuvastatin, and Ezetimibe in Patients with Coexisting Hypertension and DyslipidemiaKCT0008610Pusan National University Yangsan Hospital550